# Hepatic Function During and Following Three Days of Acetaminophen Dosing in Alcoholics

> **NCT00402571** · PHASE4 · COMPLETED · sponsor: **Denver Health and Hospital Authority** · enrollment: 420 (—)

## Conditions studied

- Alcohol Related Disorders

## Interventions

- **DRUG:** acetaminophen

## Key facts

- **NCT ID:** NCT00402571
- **Lead sponsor:** Denver Health and Hospital Authority
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** —
- **Final completion:** 2004-07
- **Target enrollment:** 420 (—)
- **Last updated:** 2009-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00402571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00402571, "Hepatic Function During and Following Three Days of Acetaminophen Dosing in Alcoholics". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00402571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*